Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 71

2.
3.

A new model for ductal carcinoma in situ suggests strategies for treatment.

Gullick WJ.

Breast Cancer Res. 2002;4(5):176-8. Epub 2002 Jul 19. Review.

4.

Studies of epidermal growth factor receptor inhibition in breast cancer.

Bundred NJ, Chan K, Anderson NG.

Endocr Relat Cancer. 2001 Sep;8(3):183-9. Review.

5.

Linkage between EGFR family receptors and nuclear factor kappaB (NF-kappaB) signaling in breast cancer.

Biswas DK, Iglehart JD.

J Cell Physiol. 2006 Dec;209(3):645-52. Review.

PMID:
17001676
6.

Mucinous cystadenocarcinoma of the breast coexisting with infiltrating ductal carcinoma.

Chen WY, Chen CS, Chen HC, Hung YJ, Chu JS.

Pathol Int. 2004 Oct;54(10):781-6. Review.

PMID:
15482568
7.

Tumor characteristics as predictors of local recurrence after treatment of ductal carcinoma in situ: a meta-analysis.

Wang SY, Shamliyan T, Virnig BA, Kane R.

Breast Cancer Res Treat. 2011 May;127(1):1-14. doi: 10.1007/s10549-011-1387-4. Epub 2011 Feb 15. Review.

PMID:
21327465
8.
9.

Cystic hypersecretory carcinoma: rare and poorly recognized variant of intraductal carcinoma of the breast. Report of five cases.

Skalova A, Ryska A, Kajo K, Di Palma S, Kinkor Z, Michal M.

Histopathology. 2005 Jan;46(1):43-9. Review.

PMID:
15656885
10.
11.

Breast cancer precursors revisited: molecular features and progression pathways.

Lopez-Garcia MA, Geyer FC, Lacroix-Triki M, MarchiĆ³ C, Reis-Filho JS.

Histopathology. 2010 Aug;57(2):171-92. doi: 10.1111/j.1365-2559.2010.03568.x. Epub 2010 May 24. Review.

PMID:
20500230
12.

Molecular markers and therapeutic targets in ductal carcinoma in situ.

Boland GP, Knox WF, Bundred NJ.

Microsc Res Tech. 2002 Oct 1;59(1):3-11. Review.

PMID:
12242692
13.

Prognostic and predictive molecular markers in DCIS: a review.

Nofech-Mozes S, Spayne J, Rakovitch E, Hanna W.

Adv Anat Pathol. 2005 Sep;12(5):256-64. Review.

PMID:
16210921
14.

Small cell carcinoma of the breast.

Mirza IA, Shahab N.

Semin Oncol. 2007 Feb;34(1):64-6. Review.

PMID:
17270668
15.
16.

Mammary stem cells and breast cancer--role of Notch signalling.

Farnie G, Clarke RB.

Stem Cell Rev. 2007 Jun;3(2):169-75. Review.

PMID:
17873349
17.

c-erbB-2 amplification in mammary carcinoma.

Barnes DM.

J Cell Biochem Suppl. 1993;17G:132-8. Review.

PMID:
7911860
18.

Molecular evolutionary patterns in breast cancer.

Shackney SE, Silverman JF.

Adv Anat Pathol. 2003 Sep;10(5):278-90. Review.

PMID:
12973049
19.

In search of triple-negative DCIS: tumor-type dependent model of breast cancer progression from DCIS to the invasive cancer.

Kurbel S.

Tumour Biol. 2013 Feb;34(1):1-7. doi: 10.1007/s13277-012-0602-1. Epub 2012 Dec 4. Review.

PMID:
23208673
20.

The neu-oncogene: more than a prognostic indicator?

De Potter CR.

Hum Pathol. 1994 Dec;25(12):1264-8. Review.

PMID:
8001919

Supplemental Content

Support Center